Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
fda
gene therapy
life sciences
national
national blog main
national top stories
new york top stories
novartis
nusinersen
2
×
san francisco top stories
spinal muscular atrophy
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
billy dunn
bio
biome
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
celgene
cervical cancer
clinical study
clinical trial
clinical trials
commissioner
crispr
crispr therapeutics
What
new
allogene
approved
atrophy
bio
cancer
crispr
daily
diversity
drug
evrysdi
fda
friday
green
home
hot
immunotherapy
intended
investors
ipo
juno
lights
liquid
medicine
million
muscular
nearly
oral
patients
remains
risdiplam
roche
roundup
shares
snapped
spinal
therapeutics
therapy
ticket
utero
Language
unset
Current search:
nusinersen
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More